The St. Johns County Sheriff’s Office has closed its investigation into the death of a man who died during a dental implant procedure in Ponte Vedra, determining that no criminal charges will be filed. The decision follows the release of a detailed medical examiner’s report which concluded that a combined drug toxicity caused the Ponte Vedra dental patient’s death, classifying the event as an accident.
Roy Estes III died during the procedure, leaving his family to wait five months for definitive answers. The resulting 25-page autopsy report identifies the cause of death as a “combined toxicity of mitragynine, fluoxetine, diphenhydramine, and bupivacaine.” According to the medical examiner, these substances were present in the patient’s system at levels within reported toxic ranges.
While the criminal case is closed, the dentist involved, Dr. Sebastiani, remains under regulatory scrutiny. State records indicate that while his license is currently active, he is facing two separate administrative complaints filed by the Florida Department of Health that could potentially lead to the revocation of his license.
The Chemistry of a Tragedy
The autopsy revealed a lethal intersection of self-administered substances and clinical anesthesia. The medical examiner’s report highlights a “combined mitragynine-associated cardiotoxicity” that was further potentiated by the presence of other medications. Mitragynine is the primary active alkaloid found in kratom, a herbal supplement that some individuals use as a natural alternative to traditional pain medication.
As a physician and medical writer, drug-drug interactions can create unpredictable and dangerous physiological responses, particularly during surgical procedures where the body is already under stress. In this case, the interaction involved a cocktail of an antidepressant (fluoxetine), a common over-the-counter antihistamine (diphenhydramine, known as Benadryl), and a long-acting local anesthetic (bupivacaine) used in dental function.
| Substance | Common Source/Use | Role in Case |
|---|---|---|
| Mitragynine | Kratom (Herbal supplement) | Self-administered for pain |
| Fluoxetine | Antidepressant (SSRI) | Prescription medication |
| Diphenhydramine | Benadryl (Antihistamine) | Over-the-counter medication |
| Bupivacaine | Local Anesthetic | Administered during dental procedure |
Dr. Dan Schultz, a forensic pathologist and founder of the Tampa-based lab Final Diagnosis, reviewed the findings and agreed with the medical examiner’s synopsis. Dr. Schultz noted that the most remarkable aspect of the case is that the majority of the agents involved were typically self-administered by the patient.
A Dispute Over Disclosure
The central point of contention between the family and the dental office is whether Dr. Sebastiani was fully aware of the medications Roy Estes III was taking. Amy Rowell, the fiancé of Mr. Estes, maintains that he was transparent about his health history and supplement use.
Rowell stated that Estes used kratom to manage pain following a car accident in 2023 as he preferred a more natural approach than traditional pain pills. She recalls Estes providing a list of his medications to the dentist prior to the appointment and believes the doctor was informed of his history, including a diagnosis of sleep apnea.
“He had asked him all the medicines he’s taken, and he gave him the list of the stuff prior to even coming there,” Rowell said. “And then, like I’d even asked him, you know, about if he realized that he had sleep apnea and if he had all the precautions and procedures in place to, you know, if he stopped breathing.”
However, Dr. Sebastiani’s legal counsel, Rick Ramsey, stated that the dentist disputes the claim that he was told everything the patient was taking. In a statement, Ramsey emphasized that This proves essential for patients to provide a complete medical history to ensure procedures are completed safely, adding that Dr. Sebastiani is “deeply saddened by this tragic loss.”
Regulatory Scrutiny and Prior Incidents
While the Sheriff’s Office determined there was no criminal intent or negligence rising to the level of a crime, the Florida Department of Health is pursuing administrative discipline. These complaints focus on the “standard of care,” a clinical benchmark that differs from criminal liability.
One of the administrative complaints stems from the 2023 death of another patient, Colleen Krause Straw, who died days after complications from a dental implant procedure. That complaint alleges that Dr. Sebastiani failed to meet the minimum standard of care, specifically citing a failure to properly monitor and record respiration and vital signs.
A second, more recent complaint alleges a violation of Florida statutes regarding fraudulent, false, deceptive, or misleading advertising on the dentist’s website. This complaint was filed in March, and according to attorney Jon Pellett, the Health Department has a window of 45 days from March 24, 2025, to refer the case to the Division of Administrative Hearings (DOAH).
Dr. Schultz clarified that the role of a medical examiner is to determine why a person died, whereas the determination of whether the “standard of care” was met is a separate regulatory and legal matter.
The Human Toll
For Amy Rowell and the family of Roy Estes III, the closure of the criminal investigation provides little solace. Rowell described the news that no charges would be filed as a “hit in the stomach,” expressing a sense of heartbreak and anger that the legal system viewed the death as a mere accident.
“I miss being able to talk to him,” Rowell said. “He was my partner and my best friend… There is definitely a large hole with everybody that knew him because he cared deeply about people and helping them.”
Disclaimer: This article is for informational purposes only and does not constitute medical or legal advice. Always consult with a licensed healthcare provider regarding medication interactions and a qualified attorney for legal matters.
The next significant legal development is expected in Jacksonville, where a three-day administrative hearing regarding the case of Colleen Krause Straw could begin as soon as April 22, 2026.
Do you have questions about patient safety or medical disclosures? Share your thoughts in the comments or share this story to raise awareness about drug interactions.
Related reading
